Kura Oncology, Inc.

KURA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

800M

Short interest (May 15)

17.6%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.37%

↑ 31.0%

Available Shares

↓ 23.0%

Price Chart

Company Overview

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001422143

Asset Type: CS

Market Data

Market Cap: $796,306,054

Employees: 260

Status: Active

Short Interest

Current Borrow Fee 0.37%

Range: 0.28% - 0.40%

Available Shares 3M

Range: 2.8M - 2.9M

Recent Changes

Fee Change: ↓ 8.2%

Available Change: ↓ 8.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime